 MedIndia |
See More About:
About – News & Issues There is good news and bad news about Xolair (omalizumab), a newer asthma treat for kids. The good news is that a new study in the New England Journal of Medicine, Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children, … Adult Asthma Drug Nearly Eliminates Seasonal Attacks in Kids Xolair helps reduce seasonal asthma attacks in children–study Xolair Helps Alleviate Kids' Seasonal Asthma Flares |
View full post on asthma – Google News